Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

GLP systems Track

K-Number: K213486 · 2022-03-10

Decision Date2022-03-10
Product CodeJGS
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

GLP systems Track is a medical device manufactured by Abbott Laboratories. It received FDA 510(k) clearance on 2022-03-10 under approval number K213486. The device is classified under product code JGS. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the GLP systems Track?

GLP systems Track is a medical device that received FDA 510(k) clearance on 2022-03-10. It is manufactured by Abbott Laboratories. The 510(k) number is K213486.

When was GLP systems Track approved by the FDA?

GLP systems Track received FDA 510(k) clearance on 2022-03-10, under approval number K213486.

What company makes GLP systems Track?

GLP systems Track is manufactured by Abbott Laboratories.

What is the FDA product code for GLP systems Track?

The FDA product code for GLP systems Track is JGS.

Related Clinical Trials

Other Devices by Abbott Laboratories

View all 34 devices →

Related Devices (Code: JGS)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.